FIVE-YEAR OUTCOMES OF ENDOVENOUS CYANOACRYLATE GLUE ABLATION FOR LOWER LIMB VARICOSE VEINS AT FRIENDSHIP HOSPITAL
Main Article Content
Abstract
Objectives: To describe clinical and duplex ultrasound characteristics and evaluate the outcomes of endovenous cyanoacrylate glue ablation for chronic lower extremity venous insufficiency at Friendship Hospital.
Subjects and methods: A descriptive, retrospective combined with prospective longitudinal study was conducted on 53 patients (85 limbs) diagnosed with chronic great saphenous vein insufficiency who underwent cyanoacrylate glue ablation (Venaseal) from March 2019 to March 2024. Patients were followed up at 1 month and 6 months post-intervention.
Results: The mean age was 68.3 ± 12.1 years; females accounted for 52.8%. The most common symptom was leg heaviness/pain (95.3%). CEAP clinical classes were primarily C2 (50.6%) and C3 (45.9%). The mean VCSS score decreased significantly from 7.9 pre-operatively to 2.2 at 1 month and 1.6 at 6 months (p < 0.001). The complete vein closure rate was 100%. The main complication was a mild phlebitis-like abnormal reaction (PLAR) in 10.6%. No major complications were recorded.
Conclusion: Endovenous cyanoacrylate glue ablation is a safe and highly effective method, leading to rapid improvement in clinical symptoms for patients with chronic venous insufficiency.
Article Details
Keywords
Cyanoacrylate endovenous ablation, great saphenous vein insufficiency, endovenous intervention.
References
[2] Tang T.Y et al. Early results of an Asian prospective multicenter VenaSeal real-world postmarket evaluation to investigate the efficacy and safety of cyanoacrylate endovenous ablation for varicose veins. J Vasc Surg Venous Lymphat Disord, 2021, 9 (2): 335-345.e2. doi: 10.1016/j.jvsv.2020.03.020.
[3] De Maeseneer M.G et al. European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg, 2022, 63 (2): 184-267. doi: 10.1016/j.ejvs.2021.12.024.
[4] Nguyễn Vân Anh. Đánh giá hiệu quả sớm điều trị suy tĩnh mạch hiển lớn mạn tính bằng sóng có tần số radio. Luận văn thạc sĩ y học, Trường Đại học Y Hà Nội, 2014.
[5] Morrison N et al. VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord, 2017, 5 (3): 321-330. doi: 10.1016/j.jvsv.2016.12.005.
[6] Alhewy M.A et al. Outcomes of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. Annals of Vascular Surgery, 2024, 98: 309-316. doi: 10.1016/j.avsg.2023.08.016.
[7] Proebstle T.M et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord, 2015, 3 (1): 2-7. doi: 10.1016/j.jvsv.2014.09.001.
[8] Keles E. Complications of cyanoacrylate adhesive closure therapy in chronic venous insufficiency: a single center, single-surgeon study. Phlebology, 2023, 38 (8): 550-555. doi: 10.1177/02683555231190266.
[9] Cengiz Güven et al. Comparison of stripping/ligation and embolization with cyanoacrylate in venous insufficiency treatment. Journal of Surgery and Medicine, 2020, 4 (5): 400-405. doi: https://doi.org/10.28982/josam.732821.